| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |